Addressing Tetrachloroethylene Exposure in an Impacted Community
Part of paid clinical trials in West Lafayette, Indiana.
- Sponsor
- Purdue University
- Study ID
- NCT05819996
- Status
- Recruiting
Conditions
- Cancer
- Vapors; Inhalation
- Volatile Organic Compounds
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Environmental educational campaign — BEHAVIORALEducational campaign will be conducted to promote participation in indoor air testing.
Study Details
Groundwater in Martinsville, IN, is contaminated by volatile organic compounds (VOCs), tetrachloroethylene (PCE) and trichloroethylene (TCE). Indoor air in some residential and commercial buildings is also contaminated with PCE and TCE. This study is being conducted to better understand the impact of low-level exposures to these compounds on community members' health. Data collected in this study will be used to help the community identify a course of action.
Key Dates
- Start date
- Feb 17, 2023
- Status verified
- May 2024
- Primary completion
- May 31, 2028
- Completion
- May 31, 2028
Study Design
- Enrollment
- 510 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Other: Martinsville ResidentsResidents of Martinsville, Indiana, will receive educational campaign promoting participation in environmental testing
Primary Outcome Measure
Change in concerns about environmental chemical contamination in Martinsville. [ Time Frame: For Measure 1a, Time frame is from year 1 to year 3; for Measure 1b, Time frame is from year 1 to year 5. ]
Central Contacts
- Sa Liu, MPH, PhD765-496-6240
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Purdue University | West Lafayette | Indiana | 47907 |
Find similar trials in West Lafayette, IN
By research site
Related Studies
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- Daily Hand-Held Vibration TherapyRecruiting · Indiana University · Avon, Indiana
- An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid TumorsPHASE1 · Recruiting · Shenzhen Ionova Life Sciences Co., Ltd. · Lafayette, Indiana
- TTX-080 HLA-G Antagonist in Subjects With Advanced CancersPHASE1 · Recruiting · Tizona Therapeutics, Inc · Tucson, Arizona